Literature DB >> 4349629

Experimental herpes simplex encephalitis. Treatment with pyrimidine nucleosides.

H S Panitch, J R Baringer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4349629     DOI: 10.1001/archneur.1973.00490240031003

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  7 in total

1.  Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyladenine.

Authors:  E R Kern; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

2.  Acute viral encephalitis.

Authors:  H Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-10

3.  Assessment of cytosine arabinoside as an antiviral agent in humans.

Authors:  C B Lauter; E J Bailey; A M Lerner
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

4.  Variables influencing the in vitro susceptibilities of herpes simplex viruses to antiviral drugs.

Authors:  M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

5.  Brain monoamine metabolism and rotational behaviour induced by experimental herpes simplex virus encephalitis.

Authors:  M A Päivärinta; R J Marttila; M Koulu; U Pesonen; M Röyttä; U K Rinne
Journal:  J Neural Transm Gen Sect       Date:  1991

6.  Nervous system inflammatory lesions and viral nucleic acids in rabbits with herpes simplex virus encephalitis-induced rotational behaviour.

Authors:  M A Päivärinta; M Röyttä; V Hukkanen; R J Marttila; U K Rinne
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  The Senolytic Drug JQ1 Removes Senescent Cells via Ferroptosis.

Authors:  Seokhyeong Go; Mikyung Kang; Sung Pil Kwon; Mungyo Jung; Ok Hee Jeon; Byung-Soo Kim
Journal:  Tissue Eng Regen Med       Date:  2021-05-18       Impact factor: 4.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.